Search
for
Sort by
Research 421–450 of 1000+
- Potassium channel openers: therapeutic potential in cardiology and medicine
- Androgenetic alopecia; drug safety and therapeutic strategies
- Derma rollers in therapy: the transition from cosmetics to transdermal drug delivery
- Comparison of the Therapeutic Effect of Allogeneic and Xenogeneic Small Extracellular Vesicles in Soft Tissue Repair
- Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
- Alopecia Areata After Initiation of Secukinumab Therapy for Plaque Psoriasis
- Low-level light therapy using a helmet-type device for the treatment of androgenetic alopecia
- Impact of Laser Therapy on the Quality of Life in Women Living With Polycystic Ovary Syndrome-Associated Hirsutism: An Observational Study
- The Role of Patients in Alopecia Areata Endpoint Development: Understanding Physical Signs and Symptoms
- Dermoscopic evaluation of therapeutic response to intralesional triamcinolone acetonide in the treatment of Alopecia areata
- Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy
- Compounding as a Current Therapeutic Option in Dermatology
- FINASTERIDE IN MODERN MEDICINE: THERAPEUTIC APPLICATIONS AND SYSTEMIC HEALTH IMPLICATIONS
- Microneedles meet photomedicine: emerging strategies for diagnosis and therapy of skin diseases
- Journal of Population Therapeutics and Clinical Pharmacology
- Low-Level Laser Therapy: A Comprehensive Review of Anti- Inflammatory Applications and Therapeutic Potential
- Epidemiological and Clinico-therapeutic Studies on Dermatophytosis in Cattle at Parbhani
- Advances In Mesenchymal Cell Therapy In Dermatology And Aesthetic Medicine
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Phytochemicals as emerging therapeutic agents for alopecia treatment
- Cutaneous Syndromes Produced as Side Effects of Triparanol Therapy
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
- The safety of 52 weeks of oral DHEA therapy for postmenopausal women
- Reversible alopecia universalis secondary to PEG-interferon ??-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection
- FOXN1 Deficiency: from the Discovery to Novel Therapeutic Approaches
- RASopathic alopecia: Hair changes associated with vemurafenib therapy
- Melatonin-Loaded Nanocarriers: New Horizons for Therapeutic Applications
- MoS2 Nanoclusters-based biomaterials for disease- impaired wound therapy
- Current standards in the diagnostics and therapy of hair diseases - hair consultation
- The Potential Application of Exosomes as Therapeutic Agents, Carriers, and Biomarkers in Skin Diseases